Add to ORKGZinc and tetrathiomolybdate, effective, nontoxic drugs, have now been added to the treat-ment of most phases of Wilson’s disease. Zinc is used for maintenance as well as treating presymptomatic, pregnant, and pediatric patients. Tetrathiomolybdate is the choice for patients presenting with neurologic diseases. J. Trace Elem. Exp. Med. 13:51–61
Background: Wilson disease (WD) is an inherited neurometabolic disorder that results in excessive co...
Exclusive monotherapy with zinc in symptomatic Wilson disease is controversial. Seventeen symptomati...
The need for agents to lower body copper in Wilson's disease, a disease which results from copper to...
Zinc and tetrathiomolybdate, effective, nontoxic drugs, have now been added to the treatment of most...
J Hui,1 NL Tang21Department of Pediatrics, 2Department of Chemical Pathology, Prince of Wales Hospit...
International audienceBackground and Aims: Zinc therapy is considered a good option in Wilson diseas...
The aim – to study the effectiveness of zinc salts in the treatment of patients with neurological fo...
Wilson's Disease is a rare genetic disorder with the prevalence of 1 in every 30,000 people, due to ...
To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment...
We report our experience with zinc (Zn) therapy in five patients with Wilson's disease (WD). In addi...
Wilson's disease is an inherited disorder of copper accumulation that is fatal if untreated. Be...
The standard therapy for preventing copper accumulation in Wilson's disease, D-penicillamine, has be...
OPINION STATEMENT: Medical treatment in Wilson's disease includes chelators (D-penicillamine and tri...
Therapy of Wilson's disease continues to evolve. In 1997, zinc acetate was added to the list of drug...
INTRODUCTION : Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism which ...
Background: Wilson disease (WD) is an inherited neurometabolic disorder that results in excessive co...
Exclusive monotherapy with zinc in symptomatic Wilson disease is controversial. Seventeen symptomati...
The need for agents to lower body copper in Wilson's disease, a disease which results from copper to...
Zinc and tetrathiomolybdate, effective, nontoxic drugs, have now been added to the treatment of most...
J Hui,1 NL Tang21Department of Pediatrics, 2Department of Chemical Pathology, Prince of Wales Hospit...
International audienceBackground and Aims: Zinc therapy is considered a good option in Wilson diseas...
The aim – to study the effectiveness of zinc salts in the treatment of patients with neurological fo...
Wilson's Disease is a rare genetic disorder with the prevalence of 1 in every 30,000 people, due to ...
To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment...
We report our experience with zinc (Zn) therapy in five patients with Wilson's disease (WD). In addi...
Wilson's disease is an inherited disorder of copper accumulation that is fatal if untreated. Be...
The standard therapy for preventing copper accumulation in Wilson's disease, D-penicillamine, has be...
OPINION STATEMENT: Medical treatment in Wilson's disease includes chelators (D-penicillamine and tri...
Therapy of Wilson's disease continues to evolve. In 1997, zinc acetate was added to the list of drug...
INTRODUCTION : Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism which ...
Background: Wilson disease (WD) is an inherited neurometabolic disorder that results in excessive co...
Exclusive monotherapy with zinc in symptomatic Wilson disease is controversial. Seventeen symptomati...
The need for agents to lower body copper in Wilson's disease, a disease which results from copper to...